Nov 17, 2026
Dr. Felix Wagner Receives Innovation Prize of the Industrieclub Sachsen
From left to right: Regina Kraushaar, Prof. Ursula M. Staudinger, Dr. Felix Wagner, Prof. Mike O. Karl, Ulrich Franzen
At a ceremony at Schloss Eckberg on November 10, 2026, Dr. Felix Wagner received the 34th Innovation Prize of the Industrieclub Sachsen e.V. for his doctoral thesis. Conducted under the supervision of Prof. Mike O. Karl at the Center for Regenerative Therapies Dresden (CRTD) at TUD Dresden University of Technology and the German Center for Neurodegenerative Diseases (DZNE) his research laid the foundation for MaculaPatch, a project developing a cell replacement therapy to restore vision.
In his doctoral thesis, Dr. Felix Wagner addressed one of the biggest unsolved challenges of ophthalmology: the loss of light-sensitive photoreceptor cells in the retina. Age-related macular degeneration (AMD) is the leading cause of vision loss in industrialized countries but still lacks effective preventive or restorative therapies.
Dr. Wagner contributed to establishing human retina organoids, small organ-like structures grown from stem cells in the laboratory that resemble the human retina, as a research platform to study pathology and develop therapeutic approaches. His work contributed to the discovery of a previously unknown mechanism of photoreceptor loss. By establishing human organoids as a research platform for cell therapy development, Dr. Wagner performed the first systematic studies of transplant integration into a human recipient retina.
“Organoid technology has existed for only about 15 years. Within my thesis I could demonstrate their power to identify new disease mechanisms and to develop therapeutic strategies. I am sure that organoids will be key to developing relevant therapies for patients and to effectively translate them from fundamental research into clinical application,” says Dr. Wagner.
His work became the foundation for MaculaPatch, a translational project developing the first precise cell therapy for vision loss. Building on his thesis, the team engineers three-dimensional patches from purified photoreceptor cells that can be tailored to the damaged area of each patient’s retina. MaculaPatch is funded by the GO-Bio program of the Federal Ministry of Research, Technology, and Space (BMFTR).
“Receiving a prize from the Industrieclub Sachsen means a lot to me, because it recognizes not only the science but also its potential for application. Being the first awardee from the field of biology and medicine is a great honor and encouragement for our team to follow our translational path,” says Dr. Wagner.
About the Innovation Prize
Since 1997, the Industrieclub Sachsen e.V. has honored outstanding doctoral theses at TUD Dresden University of Technology that combine scientific excellence with strong practical relevance. The prize is endowed with 5,000 EUR.